Reason for ibrutinib discontinuation
| Reason for discontinuation . | Number of patients who discontinued . | Percentage among all IR patients who started IR, n = 352 . | Percentage among IR patients discontinuing treatment, n = 138 . |
|---|---|---|---|
| Progression or death | 37 | 10.5 | 26.8 |
| AE or complications | 77 | 21.9 | 55.8 |
| Withdrawal or other reason* | 24 | 6.8 | 17.4 |
| Reason for discontinuation . | Number of patients who discontinued . | Percentage among all IR patients who started IR, n = 352 . | Percentage among IR patients discontinuing treatment, n = 138 . |
|---|---|---|---|
| Progression or death | 37 | 10.5 | 26.8 |
| AE or complications | 77 | 21.9 | 55.8 |
| Withdrawal or other reason* | 24 | 6.8 | 17.4 |
Other reasons: lost insurance (n = 2), missed visits or noncompliance (n = 5), moved to a new location or site (n = 3).